Previous close | 0.1574 |
Open | 0.1520 |
Bid | 0.1490 x 400 |
Ask | 0.1533 x 400 |
Day's range | 0.1452 - 0.1559 |
52-week range | 0.1300 - 10.0000 |
Volume | |
Avg. volume | 4,884,857 |
Market cap | 5.143M |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 24 Jun 2005 |
1y target est | N/A |
Discover how Biolase Inc navigates market dynamics with robust revenue projections and significant operational efficiencies.
BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript March 21, 2024 BIOLASE, Inc. beats earnings expectations. Reported EPS is $-1.76, expectations were $-2.56. BIOL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to the BIOLASE Fourth […]